SAAB to onshore defence health system business

SAAB Australia is to relocate its global Deployable Health System Design and Development Centre from Europe to Australia following the win of a $370 million defence contract to deliver cutting-edge deployable health equipment. The first five-years of the contract will see Saab Australia enhance the ADF’s clinical health care response capability by delivering more than…

Highlights from the 4th International Forum on Additive Manufacturing 

By RMIT Advanced Manufacturing Precinct and Centre for Additive Manufacture The 4th International Forum on Additive Manufacturing, delivered virtually on 9 September, 2020 in Melbourne, Australia proved by all accounts to be a great success.  The Forum general chair Professor Milan Brandt of the Centre for Additive Manufacturing, RMIT University attracted a number of international,…

Glaciem wins engineering award for CO2 Refrigeration

South Australia’s Glaciem Cooling Technologies has won the state’s Engineering Excellence Award and been named as Sir William Hudson Award finalist. The company was recognised for several technologies based on research at the University of South Australia. Their air-cooled CO2 refrigeration system has been operating at The Bend Motorsport Park, about 100km southeast of Adelaide,…

1414 Degrees looks to add batteries to silicon energy storage

Thermal energy storage developer 1414 Degrees has evaluated its TESS molten silicon technology for energy storage under scenarios linked to additional battery storage. The company, which is developing the Silicon Aurora project near Port Augusta in South Australia, found the project would generate higher revenues by combining thermal (TESS) and battery enetrgy (BESS) storage. The…

Recce Pharmaceuticals raises $29 million

Anti-infective drug developer Recce Pharmaceuticals has received commitments from investors for $27,950,000 to be raised in a placement of shares. The capital raising will fast track commercialisation activities and fund human clinical trials. The company has been developing broad spectrum synthetic drugs which have achieved ‘positive results’ in pre-clinical laboratory and animal tests on E.…

Will we learn from the past and seize the opportunity of a post-Covid world

By Peter Roberts Standing in front of Chateau Tanunda in the Barossa Valley yesterday hit home a lesson of the past – where there is trouble, there is also opportunity. The Château’s origins go back to the decimation of Europe’s, and Australia’s eastern states’ vineyards by the fungal root disease phylloxera in the 19th century.…